TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wang Guoping¹,Mudgal Poorva²,Wang Liuyang³,Shuen Timothy Wai Ho⁴,Wu Haiyang²,Alexander Peter B²,Wang Who-Whong⁴,Wan Ying⁵^ORCID,Toh Han Chong⁴,Wang Xiao-Fan⁶,Li Qi-Jing¹

Affiliation:

1. Department of Immunology, Duke University Medical Center, Durham, NC, USA

2. TCRCure Biopharma Ltd, Durham, NC, USA

3. Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA

4. Division of Medical Oncology, National Cancer Centre Singapore, Singapore

5. Biomedical Analysis Center, Army Medical University, Chongqing, China

6. Departments of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA

Funder

Duke University

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1955545

Reference53 articles.

1. Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety

2. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

3. Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

4. 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations

5. Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo;Science Advances;2024-08-23

2. Radiomics and Deep Learning in Nasopharyngeal Carcinoma: A Review;IEEE Reviews in Biomedical Engineering;2024

3. A deep learning MRI-based signature may provide risk-stratification strategies for nasopharyngeal carcinoma;European Archives of Oto-Rhino-Laryngology;2023-06-26

4. Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persistin vivo;2023-06-01

5. GENTLE: a novel bioinformatics tool for generating features and building classifiers from T cell repertoire cancer data;BMC Bioinformatics;2023-01-30